Cardiol Therapeutics Inc
F:CT9
Cardiol Therapeutics Inc
F:CT9
Price:
1.778
EUR
-3.47%
Market Closed
Market Cap:
€123.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cardiol Therapeutics Inc
F:CT9
|
CA |
|
H
|
Huabao International Holdings Ltd
XMUN:CEY2
|
HK |
|
Turners Automotive Group Ltd
ASX:TRA
|
NZ |
|
G
|
Greenhawk Resources Inc
F:2V70
|
CA |
|
C
|
China Communications Construction Co Ltd
XMUN:CYY
|
CN |
|
F
|
Fireweed Zinc Ltd
F:20F
|
CA |
|
B
|
B&G Foods Inc
DUS:DHR
|
US |
|
CropEnergies AG
F:CE2
|
DE |
|
I
|
Indiana Resources Ltd
F:GDM
|
AU |
|
Ecomiam SA
F:602
|
FR |
Wall St Price Targets
CT9 Price Targets Summary
Cardiol Therapeutics Inc
Cardiol Therapeutics Inc
Wall Street analysts forecast CT9 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CT9 is 2.356 EUR with a low forecast of 2.246 EUR and a high forecast of 2.517 EUR.
Lowest Forecast
Price Target
2.246
EUR
26% Upside
Average Forecast
Price Target
2.356
EUR
33% Upside
Highest Forecast
Price Target
2.517
EUR
42% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CT9's stock price target?
Price Target
2.356
EUR
2.356
EUR
According to Wall Street analysts, the average 1-year price target for CT9 is 2.356 EUR with a low forecast of 2.246 EUR and a high forecast of 2.517 EUR.
